MetaCap

Black Titan (BTTC) vs VivoSim Labs (VIVS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Black Titan is the larger company by market cap ($6.5 million vs $3.0 million), about 2.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BTTC-7.23%VIVS-5.95%
+0%-4%-8%
Oct 7, 20261 yearOct 9, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BTTC versus VIVS key metrics
MetricBTTCVIVS
Share price$0.4759$0.1801
Market cap$6.52M$2.99M
1-day change-3.86%+1.64%
EPS (TTM)$-0.46$-4.55
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$10.05$3.41
52-week low$0.342$0.1681
Distance from 52-week high-95.26%-94.72%
Average volume11.84M5.85M
Shares outstanding13.70M16.59M
Employees—15
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Black Titan is about 2.2 times larger than VivoSim Labs by market value ($6.52M vs $2.99M).

About VivoSim Labs

VIVS stock →

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 15 employees

BTTC vs VIVS FAQ

Which is bigger, Black Titan or VivoSim Labs?

Black Titan (BTTC) is larger, with a market capitalization of $6.52M compared with $2.99M for VivoSim Labs (VIVS).

Are Black Titan and VivoSim Labs in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons